Part one of a two-part series. Part two will be published on June 5.
Pharmacy benefit managers (PBMs) occupy a central position in the prescription drug supply chain, administering prescription drug benefits for most commercially insured Americans.

Part one of a two-part series. Part two will be published on June 5.
Pharmacy benefit managers (PBMs) occupy a central position in the prescription drug supply chain, administering prescription drug benefits for most commercially insured Americans.
Simon Leung PharmD, RPh is VP, head of pharmacy at Conner Strong & Buckelew, one of America's largest and most respected insurance brokerage, employee benefits and risk management consulting … Read full bio
For reprint and licensing requests for this article, click here.
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
As costs to treat serious conditions surge, employers must plan how to absorb budget-altering expenses ahead of time.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
Rising use of the weight-loss drug is fueling the fastest health plan cost growth in a decade and a half, forcing employers to rethink coverage strategies and cost management.